Life Science Success
PODCAST: 12/22/2022 (December 12, 2022) | By Life Science Success. In this episode of Life Science Success, my guest is Ross Youngs. Ross is the CEO and Founder of Biosortia
Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing
Enveda Biosciences Closes $68-million Combined Series B Equity and Debt Financing (December 21, 2022) BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences today announced that it has closed a $68-million equity and debt financing.
Wave Life Sciences to receive $170M upfront in new partnership with GSK to develop a large number of candidates
Wave Life Sciences to receive $170M upfront in new partnership with GSK to develop a large number of candidates (December 13, 2022) | By Tyler Patchen. Wave Life Sciences has
Amgen Is Said to Agree to Buy Horizon at $26 Billion Value
Amgen Is Said to Agree to Buy Horizon at $26 Billion Value (December 12, 2022) | By Katie Roof, Michelle F Davis, and Dinesh Nair. Amgen agrees to pay around
Paragon Therapeutics Launches First Spinout, Apogee Therapeutics, to Advance Novel Therapies for Inflammatory and Immunological Conditions
Paragon Therapeutics Launches First Spinout, Apogee Therapeutics, to Advance Novel Therapies for Inflammatory and Immunological Conditions (December 07, 2022) | By Paragon Therapeutics. Apogee emerges with $169 million to expand
The Microbiome Miner
The Microbiome Miner Water is the giver of life, but could it be a giver of untold medicines too? Biosortia CEO Ross Youngs believes so